Insulin Agreement Sample Contracts

Amendment to 6 August 1982 Insulin Agreement
Insulin Agreement • August 9th, 2004 • Zymogenetics Inc • Biological products, (no disgnostic substances)

This Amendment of May 18, 2004 (“Amendment Agreement”) to the Insulin Agreement and the 1987 Agreement (as defined below) is entered into between Novo Nordisk A/S, a Danish corporation having a principal place of business at Novo Alle, DK-2880, Bagsvaerd, Denmark (“Novo Nordisk”) and ZymoGenetics Inc., a Washington Corporation having a principal place of business at 1201 Eastlake Avenue East, Seattle, Washington 98102 (“ZGI”).

Sample 1
AutoNDA by SimpleDocs
Addendum to 6 August 1982 Insulin Agreement
Insulin Agreement • August 9th, 2004 • Zymogenetics Inc • Biological products, (no disgnostic substances)

This Addendum of May 18, 2004 (“Effective Date”) to the Insulin Agreement (as defined below) is entered into between Novo Nordisk A/S, a Danish corporation having a principal place of business at Novo Alle, DK-2880, Bagsvaerd, Denmark (“Novo Nordisk”) and ZymoGenetics Inc., a Washington Corporation having a principal place of business at 1201 Eastlake Avenue East, Seattle, Washington 98102 (“ZGI”).

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!